CX Institutional’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-575
Closed -$14K – 1606
2026
Q1
$14K Buy
575
+4
+0.7% +$97 ﹤0.01% 1211
2025
Q4
$14K Buy
571
+8
+1% +$194 ﹤0.01% 1153
2025
Q3
$14K Buy
+563
New +$13.7K ﹤0.01% 1150

Other funds holding IBDS

CX Institutional's IBDS Position: Q2 2026 in Review

CX Institutional sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q2 2026, closing a stake of 575 shares — an estimated $14K sold.

CX Institutional first reported a position in IBDS in Q3 2025 and held it in 3 quarters. The position peaked at $14K in Q1 2026. 418 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • CX Institutional reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q2 2026 after selling out during the quarter.
  • CX Institutional sold 575 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $14K.
  • CX Institutional first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2025 and held it in 3 quarters.
  • CX Institutional's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $14K in Q1 2026.
  • 418 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.